BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34645700)

  • 1. VITT, COVID-19 and the Expert Haematology Panel: The story of how the UK responded to emerging cases of vaccine-induced immune thrombocytopenia and thrombosis during the vaccination programme.
    Chevassut T; Hunt BJ; Pavord S
    Clin Med (Lond); 2021 Nov; 21(6):e600-e602. PubMed ID: 34645700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aortic thrombosis and acute limb ischemia after ChAdOx1 nCov-19 (Oxford-AstraZeneca) vaccination: a case of vaccine-induced thrombocytopenia and thrombosis (VITT).
    Vierstraete M; Sabbe T
    Acta Chir Belg; 2023 Jun; 123(3):329-332. PubMed ID: 34890294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective review COVID-19 vaccine induced thrombotic thrombocytopenia and cerebral venous thrombosis-what can we learn from the immune response.
    Franceschi AM; Petrover DR; McMahon TM; Libman RB; Giliberto L; Clouston SAP; Castillo M; Kirsch C
    Clin Imaging; 2022 Oct; 90():63-70. PubMed ID: 35926315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of a severe bilateral pulmonary embolism as a complication of VITT following vaccination with AstraZeneca COVID-19 vaccine.
    Elkoumy M; Schoen J; Loew A
    BMJ Case Rep; 2022 May; 15(5):. PubMed ID: 35545306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial: SARS-CoV-2 mRNA Vaccines and the Possible Mechanism of Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT).
    Parums DV
    Med Sci Monit; 2021 Apr; 27():e932899. PubMed ID: 33900279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uncommon thrombotic complications after SARS-CoV-2 vaccination.
    Musil D
    Vnitr Lek; 2021; 67(5):297-302. PubMed ID: 35459396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombosis patterns and clinical outcome of COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A Systematic Review and Meta-Analysis.
    Kim AY; Woo W; Yon DK; Lee SW; Yang JW; Kim JH; Park S; Koyanagi A; Kim MS; Lee S; Shin JI; Smith L
    Int J Infect Dis; 2022 Jun; 119():130-139. PubMed ID: 35339716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of anti-platelet factor 4 antibodies and platelet activation tests in patients with vaccine-induced immune thrombotic thrombocytopenia: Brief report on a comparison of the laboratory diagnosis and literature review.
    Hsiao PJ; Wu KL; Chen YC; Chen YL; Wang RL; Wu KA; Chan JS; Chiu CC; Huang LY; Shyu HY; Kao YH; Chuu CP
    Clin Chim Acta; 2022 Apr; 529():42-45. PubMed ID: 35167842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine-induced immune thrombotic thrombocytopenia and patients with cancer.
    Connors JM; Iba T
    Thromb Res; 2022 May; 213 Suppl 1():S77-S83. PubMed ID: 36210565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review.
    Sharifian-Dorche M; Bahmanyar M; Sharifian-Dorche A; Mohammadi P; Nomovi M; Mowla A
    J Neurol Sci; 2021 Sep; 428():117607. PubMed ID: 34365148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re-evaluation of the risk of venous thromboembolism after COVID-19 vaccination using haematological criteria.
    Shaw RJ; Doyle AJ; Millen EA; Stowe J; Tessier E; Andrews N; Miller E;
    Vaccine; 2023 Aug; 41(36):5330-5337. PubMed ID: 37495490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune thrombocytopenia following immunisation with Vaxzevria ChadOx1-S (AstraZeneca) vaccine, Victoria, Australia.
    Gordon SF; Clothier HJ; Morgan H; Buttery JP; Phuong LK; Monagle P; Chunilal S; Wood EM; Tran H; Szer J; Crawford NW;
    Vaccine; 2021 Nov; 39(48):7052-7057. PubMed ID: 34756770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine-induced immune thrombotic thrombocytopenia.
    Klok FA; Pai M; Huisman MV; Makris M
    Lancet Haematol; 2022 Jan; 9(1):e73-e80. PubMed ID: 34774202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical care pathway for the evaluation of patients with suspected VITT after ChAdOx1 nCoV-19 vaccination.
    Lee AYY; Al Moosawi M; Peterson EA; McCracken RK; Wong SKW; Nicolson H; Chan V; Smith T; Wong MP; Lee LJ; Griffiths C; Rahal B; Parkin S; Afra K; Ambler K; Chen LYC; Field TS; Lindsay HC; Lavoie M; Li C; Migneault D; Naus M; Piszczek J; Rahmani P; Sreenivasan G; Wan T; Yee A; Zypchen L; Sweet D
    Blood Adv; 2022 Jun; 6(11):3315-3320. PubMed ID: 35201292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology of Vaccine-Induced Prothrombotic Immune Thrombocytopenia (VIPIT) and Vaccine-Induced Thrombocytopenic Thrombosis (VITT) and Their Diagnostic Approach in Emergency.
    Di Micco P; Camporese G; Cardillo G; Lodigiani C; Carannante N; Annunziata A; Fiorentino G; Russo V; Imbalzano E
    Medicina (Kaunas); 2021 Sep; 57(10):. PubMed ID: 34684034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study.
    Perry RJ; Tamborska A; Singh B; Craven B; Marigold R; Arthur-Farraj P; Yeo JM; Zhang L; Hassan-Smith G; Jones M; Hutchcroft C; Hobson E; Warcel D; White D; Ferdinand P; Webb A; Solomon T; Scully M; Werring DJ; Roffe C;
    Lancet; 2021 Sep; 398(10306):1147-1156. PubMed ID: 34370972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19: Vaccine-induced immune thrombotic thrombocytopenia.
    Danish FI; Rabani AE; Subhani FE; Yasmin S; Koul SS
    Eur J Haematol; 2022 Dec; 109(6):619-632. PubMed ID: 36030503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome in vaccine-induced immune thrombocytopenia and thrombosis.
    Schönborn L; Seck SE; Thiele T; Kaderali L; Hoffmann T; Hlinka A; Lindhoff-Last E; Völker U; Selleng K; Buoninfante A; Cavaleri M; Greinacher A
    J Thromb Haemost; 2023 Sep; 21(9):2519-2527. PubMed ID: 37394120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine-induced immune thrombotic thrombocytopenia post dose 2 ChAdOx1 nCoV19 vaccination: Less severe but remains a problem.
    Clarke L; Brighton T; Chunilal SD; Lee CSM; Passam F; Curnow J; Chen VM; Tran HA
    Vaccine; 2023 May; 41(20):3285-3291. PubMed ID: 37085453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 Vaccination-Induced Thrombotic Thrombocytopenia: A Rare but Serious Immunologic Complication.
    Abrams CS; Barnes GD
    Annu Rev Med; 2023 Jan; 74():65-74. PubMed ID: 35850494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.